Navigation Links
Cell Therapeutics Submits Day 120 Response for Pixantrone Marketing Authorization Application to European Medicines Agency; Potential Q1 2012 Opinion on Approval
Date:8/22/2011

SEATTLE, Aug. 23, 2011 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) today announced that it has submitted its response to the Day 120 List of Outstanding Issues to the European Medicines Agency's (the "EMA") Committee for Medicinal Products for Human Use ("CHMP") in regards to CTI's Marketing Authorization Application for pixantrone (the "MAA") to treat relapsed or refractory aggressive non-Hodgkin's lymphoma ("NHL"). With this submission, CTI expects to receive a CHMP opinion regarding approvability of pixantrone during the first quarter of 2012.

"We have now submitted answers to the CHMP list of questions moving pixantrone a step closer to potential approval," said James A. Bianco, CEO of CTI. "Following an encouraging meeting with the EMA earlier this year and based on recommendations from the rapporteurs, we requested and received an extension to answer all the EMA's questions in the Day 120 letter. We believe we have been able to provide quality responses to each of the questions posed and we expect this positions us to receive an opinion by the early next year.  If the opinion is positive, we expect that the commercial launch of pixantrone in Europe could occur as early as the first half of 2012."

In the United States, CTI expects to resubmit its New Drug Application for pixantrone (the "NDA") to the U.S. Food and Drug Administration (the "FDA") during the fourth quarter of 2011 and the FDA has indicated the NDA would receive a six month review resulting in a decision on approval of the NDA by the FDA in the United States as early as April 2012.

About Pixantrone

Pixantrone is a novel aza-anthracenedione that has distinct structural and physio-chemical properties that make its anti-tumor activity unique in this class of agents. Similar to anthracyclines, pixantrone inhibits Topo-isomerase II but unlike anthracyclines -- rather than intercalation with DNA -- pixantrone alkylates DNA -- f
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Inhibikase Therapeutics Receives FDA Clearance for Phase II Trial of IkT-001 to Treat JC Virus Infection, the Cause of Progressive Multifocal Leukoencephalopathy (PML) in Multiple Sclerosis Patients
2. Echo Therapeutics Announces Second Quarter 2011 Financial Results
3. Halozyme Therapeutics to Present at the Wedbush 2011 Global Healthcare Conference on August 17
4. Prime Therapeutics Announces Pharmacy Offering with Guaranteed Net Spend Per Prescription
5. Echo Therapeutics Unveils Symphony tCGM Demonstration Video
6. Orexigen® Therapeutics Reports Second Quarter Ended June 30, 2011 Financial Results
7. Echo Therapeutics Announces Multiple Patents and Trademark Grants
8. Nektar Therapeutics Reports Second Quarter 2011 Financial Results
9. Silence Therapeutics Receives Notice of Allowance for New U.S. Patent Covering Novel Small Interfering RNA (siRNA) Delivery Technology
10. Prefilled Syringes: Devices, Therapeutics, Players, Markets and Prospects
11. Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)...  LCA-Vision Inc. (NASDAQ: LCAV ), a leading ... ® brand, announces that all nominees to the company,s Board ... meeting of stockholders.  These Directors are: , ... & Gaynor Investment Counsel , John C. ... Edgar F. Heizer III , Chairman of Manus ...
(Date:5/21/2013)... PHILADELPHIA , May 21, 2013 ... image and impressive new product developments at the Special Libraries ... ten years of unerring focus on product literature databases and ... to mark the occasion," said founding director Nigel ... interesting developments of benefit to our clients and what better ...
(Date:5/21/2013)... PRINCETON, N.J. , May 21, 2013 /PRNewswire/ ... consulting company, today announced that 13-year veteran ... Chief Executive Officer. Geraghty,s experience includes more than ... senior management positions with manufacturing organizations. He succeeds ... retiring after serving as Kepner-Tregoe,s Chairman of the ...
Breaking Medicine Technology:LCA-Vision Reports on Annual Meeting of Stockholders 2LCA-Vision Reports on Annual Meeting of Stockholders 3LCA-Vision Reports on Annual Meeting of Stockholders 4Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 2Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 3
(Date:5/21/2013)... 21, 2013 Children using the ... Inc., experience audiological results comparable to the traditionally ... fewer complications, according to a new study. , ... Sophono’s abutment-free technology performs just as well as ... many fewer complications,” says Jim Kasic, president and ...
(Date:5/21/2013)... New York, NY (PRWEB) May 21, 2013 ... between two international powerhouse teams - the game between ... this coming 23rd of May 2013. These two teams ... soccer and they are bringing their A-game to the Busch ... team. , This will be the first time that a ...
(Date:5/21/2013)... The risk of sudden infant death syndrome (SIDS) is ... a new study finds. British researchers noted that ... do not drink, use illegal drugs or smoke. They ... cause of infant death in developed countries, would drop ... In the United States, all parents are advised ...
(Date:5/21/2013)... tobacco packages in order to reduce consumption do not ... find some of them really unpleasant. So, if the ... anti-smoking campaigns, it should produce a new set of ... some of the conclusions of research conducted in the ... University of Granada by Miguel ngel Muoz, Luis Ciria ...
(Date:5/21/2013)... Grapefruits have long been known for their ... how medical therapies like anti-cancer drugs are delivered ... researchers have uncovered how to create nanoparticles using ... how to use them as drug delivery vehicles. ... Ph.D., and their team today (May 21, 2013), ...
Breaking Medicine News(10 mins):Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 2Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 3Health News:Manchester City vs. Chelsea FC Tickets: Cheap Concert Tickets has Slashed Prices on Manchester City vs. Chelsea FC Tickets at Busch Stadium in St. Louis, MO 2Health News:Bed-Sharing Raises SIDS Risk Fivefold, Study Finds 2Health News:Warning images for cigarette packs proposed by Europe do not make enough emotional impact 2Health News:UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery 2
... the powers of digital communications technology to help young ... chemotherapy. , They have given the teenagers and ... patients can record and send details of all their ... phones are capable of giving basic advice about the ...
... Endocrine Society will present Ronald S. Swerdloff, M.D., ... Institute at Harbor-UCLA Medical Center (LA BioMed), with ... June 15-18 in San Francisco. , The Endocrine ... the full range of disciplines associated with endocrinology, ...
... study cut desire, relapse in as little as 10 ... new treatment that reduces excessive drinking and prevents drinking ... study finds. , The treatment involves increasing levels of ... -- also being looked at as a treatment for ...
... Monday, Dad begins,to put a lot on his plate at work ... he works to keep the bacon off his plate., Here,s ... by over,2 to 1. It,s no secret that millions of men ... harmful number. High,cholesterol has been linked to a number of health ...
... Announce Plans for Celebrating World Blood Donor,Day on ... To increase national,and global appreciation of volunteer blood ... (ADRP) are partnering together to,encourage their respective members ... 14. This specific day marks the birthday of ...
... and ... the healthcare industry, LANSDALE, Pa., ... process is a big issue facing healthcare reform, says,NAIRO (National ... 44 states and Washington, D.C. have external,review laws, each is ...
Cached Medicine News:Health News:Managing symptoms by mobile phone may revolutionize cancer care for young people 2Health News:Managing symptoms by mobile phone may revolutionize cancer care for young people 3Health News:LA BioMed investigator wins Distinguished Educator Award 2Health News:New Treatment Shows Promise for Excessive Drinking 2Health News:Take the Fat Out of Father's Day! 2Health News:AABB and the Association of Donor Recruitment Professionals Partner to Recognize Blood Donors Worldwide 2Health News:AABB and the Association of Donor Recruitment Professionals Partner to Recognize Blood Donors Worldwide 3Health News:AABB and the Association of Donor Recruitment Professionals Partner to Recognize Blood Donors Worldwide 4Health News:NAIRO Supports Uniform Health Carrier External Review Model Act Adopted by NAIC 2
... Vibratome, this sapphire microtomy knife makes it ... thin Vibratome sections with microscopic resolution similar ... plastic sections. The sapphire knife allows ... a thickness in the 6-10 micron range ...
... an optional component available for Vibratome ... plugs into the back of all ... a selector switch. Once activated, ... initiating a sectioning sequence and reversing ...
... inside the existing black Vibratome bath. This ... buffer and ice kept in the original black ... has round mounting disks that can be easily ... bath surface are marked with degrees of rotation ...
... simple device designed to mount floated histological ... facilitates the mounting of all types of ... especially useful for mounting tissue slices not ... produced with a Vibratome, freezing microtome (cryostat) ...
Medicine Products: